IL6 and neoplasm: Moreover, ROS activate the mitogen-activated protein kinase (MAPK) pathway, which drives the production of pro-inflammatory cytokines like IL-1, IL-6, TNF-α, and TGF-β, leading to nuclear factor-kappa B (NF-κB) activation and tumor proliferation [60].